Evidence map›Paper›PMID 33234169›Full record

ReviewMolecular cancer2020

Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities.

Xiufang Xu, Miaofeng Zhang, Faying Xu, Shaojie Jiang

Abstract readReview
In one paragraph

Review in Molecular cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 337 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
337citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

337 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. FMRP promotes gastric cancer progression via mJournal of translational medicine · 2026
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

277 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiufang XuSchool of Medical Imaging, Hangzhou Medical College, Hangzhou, 310053, Zhejiang, China.
Miaofeng ZhangDepartment of Orthopedic Surgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, Zhejiang, China.
Faying XuSchool of Medical Imaging, Hangzhou Medical College, Hangzhou, 310053, Zhejiang, China.
Shaojie JiangSchool of Medical Imaging, Hangzhou Medical College, Hangzhou, 310053, Zhejiang, China. jsj1983@hmc.edu.cn.ORCID 0000-0001-9996-7016

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wnt signaling is a highly conserved signaling pathway that plays a critical role in controlling embryonic and organ development, as well as cancer progression. Genome-wide sequencing and gene expression profile analyses have demonstrated that Wnt signaling is involved mainly in the processes of breast cancer proliferation and metastasis. The most recent studies have indicated that Wnt signaling is also crucial in breast cancer immune microenvironment regulation, stemness maintenance, therapeutic resistance, phenotype shaping, etc. Wnt/β-Catenin, Wnt-planar cell polarity (PCP), and Wnt-Ca

Indexed as

AnimalsAntineoplastic AgentsBreast NeoplasmsFemaleHumansTumor MicroenvironmentWnt Signaling PathwayAntineoplastic AgentsBreast cancerCanonical/noncanonical Wnt signalingDrug resistanceEpithelial-mesenchymal transitionImmune microenvironmentPhenotype shapingTumoral heterogeneity

Identifiers

PMID33234169
PMCPMC7686704

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.